MedTrace Logo

Cannabis for Obesity Trial

NCT06137365 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-17

No results posted yet for this study

Summary

The goal of this study is to determine the initial efficacy of once daily oral cannabis for weight loss in obese individuals.

Conditions

Interventions

DRUG

Cannabis

Cannabis gummy product will be prepared using cannabis flower extract.

DRUG

Placebo

Placebo gummy product will be prepared using the same ingredients as the cannabis gummy but will not contain active cannabinoids.

Sponsors & Collaborators

  • Joshua A. Lile, Ph.D.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-21
Primary Completion
2028-03-31
Completion
2028-03-31
FDA Drug
Yes

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06137365 on ClinicalTrials.gov